ARTICLE | Company News
Zentaris GmbH, German Research Centre for Biotechnology mgH deal
July 12, 2004 7:00 AM UTC
Zentaris exercised an option to license from the center exclusive worldwide rights to a class of naturally occurring compounds called disorazoles plus the strain of bacteria used to produce them. Whil...